PAPILLOMAVIRUS AND GENITAL CO-INFECTIONS IN PREGNANT HIV-NEGATIVE AND HIV-POSITIVE WOMEN
Objective: to study the features of human papillomavirus (HPV) infection, combined with the co-infections of the urogenital tract in HIV-positive and HIV-negative pregnant women. Material and methods. The object of the study was 144 pregnant women examined for the presence of HPV DNA and herpes viruses in cervical scrapes. The screening for chlamydial infection was conducted by ELISA method, the culture method was used to detect genital ureaplasma infection, the diagnosis of genital candidiasis was carried out by microscopy. Results. The features of HPV infection were studied in the combination with urogenital chlamydiosis, ureaplasmosis, candidiasis, herpes infection in the HIV-positive and HIV-negative pregnant women. Conclusion. Vulvovaginal candidiasis is the most prevalent concomitant genital infection in the HPV-positive pregnant women (37,5 ± 4,9 % of cases). The HIV-positive pregnant women have concomitant genital infections (79,1 ± 6,2 %) oftener then the HIV-negative pregnant women (56,4 ± 4,9 %). The HPV-infected pregnant women with no markers of chlamydial infection and genital candidiasis reveal cervical dysplasia in combination with genital papillomatosis less often (7,5 ± 4,2 and 4,7 ± 3,2 %, respectively). Thus, there is a reverse tendency in case of U. urealyticum infection, as 43,8 ± 12,8 % of the pregnant women with ureaplasma injection observe cervical dysplasia with genital pappilomas.